MPA
IDXX icon

Marvin & Palmer Associates’s Idexx Laboratories IDXX Stock Holding History

Marvin & Palmer Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-32,200
Closed -$2.49M – 58
2015
Q1 		$2.49M Buy
32,200
+3,924
+14% +$305K 2.15% 20
2014
Q4 		$2.1M Sell
28,276
-244
-0.9% -$17.1K 2.13% 19
2014
Q3 		$1.68M Buy
28,520
+12,070
+73% +$763K 1.71% 24
2014
Q2 		$1.1M Buy
16,450
+200
+1% +$12.7K 0.95% 47
2014
Q1 		$986K Buy
+16,250
New +$968K 0.86% 46

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marvin & Palmer Associates's IDXX Position: Q2 2015 in Review

Marvin & Palmer Associates sold out of Idexx Laboratories (IDXX) in Q2 2015, closing a stake of 32,200 shares — an estimated $2.49M sold.

Marvin & Palmer Associates first reported a position in IDXX in Q1 2014 and held it in 5 quarters. The position peaked at $2.49M in Q1 2015. 348 funds tracked by Wall St. Rank hold IDXX as of Q2 2015.

  • Marvin & Palmer Associates reported no remaining Idexx Laboratories position as of Q2 2015 after selling out during the quarter.
  • Marvin & Palmer Associates sold 32,200 Idexx Laboratories shares in Q2 2015, an estimated $2.49M.
  • Marvin & Palmer Associates first reported a position in Idexx Laboratories in Q1 2014 and held it in 5 quarters.
  • Marvin & Palmer Associates's Idexx Laboratories position peaked at $2.49M in Q1 2015.
  • 348 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2015.

Based on Marvin & Palmer Associates's 13F filing for Q2 2015, filed 12 Aug 2015.